Clinical trials
Astrocytoma trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
44 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 4 |
| 2005 | 4 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 5 |
| 2010 | 1 |
| 2012 | 5 |
| 2013 | 1 |
| 2014 | 3 |
| 2015 | 1 |
| 2016 | 2 |
| 2018 | 3 |
| 2021 | 1 |
| 2022 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 44 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Children's Cancer and Leukaemia Group | 6 |
| TransMolecular | 3 |
| European Organisation for Research and Treatment of Cancer - EORTC | 2 |
| Ludwig-Maximilians - University of Munich | 2 |
| Northwestern University | 2 |
| Shandong Lanjin Pharmaceuticals Co.,Ltd | 2 |
| Sun Yat-sen University | 2 |
| All India Institute of Medical Sciences, Bhubaneswar | 1 |
| Barrett Cancer Center | 1 |
| Cancer Research UK | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Astrocytoma | 44 |
| Glioblastoma | 27 |
| Oligodendroglioma | 23 |
| Central Nervous System Neoplasms | 22 |
| Brain Neoplasms | 18 |
| Glioma | 18 |
| Gliosarcoma | 11 |
| Choroid Plexus Neoplasms | 6 |
| Ependymoma | 5 |
| Medulloblastoma | 4 |
Trials
Showing 76 to 44 of 44. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.